The Asia Pacific Neurovascular Devices Market should witness market growth of 9.6% CAGR during the forecast period (2022-2028).
Devices for neuro-thrombectomy are essential for treating ischemic stroke, a prevalent type of stroke in older people. The incidence of stroke among persons older than 40 has been linked to modern lifestyles, stress, and unhealthydietary habits. In addition, more than half of patients need physical support or assistance after a stroke event, making stroke the main cause of disability among elderly people. Correspondingly, a rise in mechanical thrombectomy treatments and a high acceptance of technologically sophisticated devices promote market growth.
Neurovascular (NV) conditions affecting the central nervous system orthe brain are the focus of interventionalneurology'sdiagnosis and treatment. Fluoroscopy, angiography, and endovascular catheters focusing on a certain function are common IN devices. Compared to cardiovascular stents, neurovascular stents need to be significantly more flexible &elastic and require much finer design and fabrication. Stents made of shape memory polymer (SMP) are more effective for neurovascular operations.
China's population is aging at one of the world's quickest rates. By 2040, there will be 28% of individuals in China who are over 60 as a result of rising life expectancy and falling fertility rates. In particular, creating an integrated system that meets the health &social needs of elderlypeople while ensuring everybody has access to healthcare, regardless of location, is one of the many new opportunities and challenges this profound demographic shift presents for public health &socioeconomic development. The region's aging population will increase the need for neurovascular devices because the elderly are more vulnerable to neurovascular diseases.
The China market dominated the Asia Pacific Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $316.9 million by 2028. The Japan market is estimated to grow a CAGR of 8.9% during (2022-2028). Additionally, The India market would experience a CAGR of 10.3% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Devices for neuro-thrombectomy are essential for treating ischemic stroke, a prevalent type of stroke in older people. The incidence of stroke among persons older than 40 has been linked to modern lifestyles, stress, and unhealthydietary habits. In addition, more than half of patients need physical support or assistance after a stroke event, making stroke the main cause of disability among elderly people. Correspondingly, a rise in mechanical thrombectomy treatments and a high acceptance of technologically sophisticated devices promote market growth.
Neurovascular (NV) conditions affecting the central nervous system orthe brain are the focus of interventionalneurology'sdiagnosis and treatment. Fluoroscopy, angiography, and endovascular catheters focusing on a certain function are common IN devices. Compared to cardiovascular stents, neurovascular stents need to be significantly more flexible &elastic and require much finer design and fabrication. Stents made of shape memory polymer (SMP) are more effective for neurovascular operations.
China's population is aging at one of the world's quickest rates. By 2040, there will be 28% of individuals in China who are over 60 as a result of rising life expectancy and falling fertility rates. In particular, creating an integrated system that meets the health &social needs of elderlypeople while ensuring everybody has access to healthcare, regardless of location, is one of the many new opportunities and challenges this profound demographic shift presents for public health &socioeconomic development. The region's aging population will increase the need for neurovascular devices because the elderly are more vulnerable to neurovascular diseases.
The China market dominated the Asia Pacific Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $316.9 million by 2028. The Japan market is estimated to grow a CAGR of 8.9% during (2022-2028). Additionally, The India market would experience a CAGR of 10.3% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Scope of the Study
By End-user
- Hospital & Surgery Centers
- Ambulatory Care Centers
- Research laboratories & Academic Institutes
By Technology
- Embolization & Coiling
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Neurothrombectomy Devices
- Clot Retrievers
- Suction & Aspiration Devices
- Snares
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Support Devices
- Microcatheters
- Microguidewires
By Disease Pathology
- Cerebral Aneuryms
- Ischemic Strokes
- Cartoid Artery Stenosis
- Arteriovenous Malformation & Fistulas (AVM)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Neurovascular Devices Market by End-user
Chapter 4. Asia Pacific Neurovascular Devices Market by Technology
Chapter 5. Asia Pacific Neurovascular Devices Market by Disease Pathology
Chapter 6. Asia Pacific Neurovascular Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
Related Reports
Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030
- Report
- 184 Pages
- Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report
- Report
- 179 Pages
- Global
From
Neurovascular Device Market
- Report
- 200 Pages
- Global
From
Neurovascular Devices Market Report by Product, End User, and Region 2024-2032
- Report
- 141 Pages
- Global
From
Neurovascular Devices Market Analysis & Forecast to 2024-2034
- Report
- 200 Pages
- Global
From
About the Market
The Neurovascular Device market is a subset of the Neurology Devices market, which focuses on the diagnosis and treatment of neurological disorders. Neurovascular Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to restore blood flow to the brain, reduce the risk of stroke, and improve patient outcomes. Neurovascular Devices include stents, embolic coils, flow diverters, and occlusion balloons. These devices are used in a variety Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
